Therapeutic areas | GSK US
WEBTo get ahead of disease, we prioritize research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach.
Therapeutic areas - GSK
WEBOur portfolio and pipeline is focused in four core therapeutic areas, which are the areas of human health we focus on to prevent and treat disease. Our infectious diseases portfolio is the broadest in the industry and, including HIV, accounts for two thirds of our pipeline.
Our product areas - GSK
WEBWe prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).
GSK Therapeutic Areas | GSKPro for Healthcare Professionals
WEBFind patient assistance programs and savings offers to help eligible patients access GSK prescription medicines and vaccines. Learn about the different therapeutic areas in relation to GSK brands. Find educational details for different disease …
Infectious diseases - GSK
WEBOur research continues to explore new therapeutic approaches for herpes including the development of novel antiviral agents and vaccines to prevent infection and reduce viral shedding, thereby providing patients with better control of outbreaks.
Therapeutic areas | GSK Canada
WEBTo get ahead of disease, we prioritize research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach.
Therapeutic areas | GSK AU
WEBTo get ahead of disease, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach.
Therapeutic areas | GSK Belgium
WEBExplore our therapeutic areas. Infectious diseases. HIV. Oncology. Respiratory & Immunology. Almost half of the vaccines and medicines under development are for infectious diseases, helping to protect people against diseases such as meningitis, shingles, influenza, polio, measles and many others.
Specialty | GSK US
WEBBuilding on decades of research and a long-term commitment to innovative science, our focus on immuno-inflammation enables us to build portfolios in therapy areas where we can make a difference in patients’ lives and health care practitioner (HCP) practices.
Therapeutic areas | GSK Pakistan
WEBTo get ahead of disease, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach.